Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Diluted EPS of $0.33 per share for fiscal year 2025.
CHAMPIONS ONCOLOGY, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.33 | +161.1% |
| 2024 | -$0.54 | -38.5% |
| 2023 | -$0.39 | -1075.0% |
| 2022 | $0.04 | +100.0% |
| 2021 | $0.02 | +111.1% |
| 2020 | -$0.18 | -1900.0% |
| 2019 | $0.01 | +107.7% |
| 2018 | -$0.13 | +27.8% |
| 2015 | -$0.18 | -63.6% |
| 2014 | -$0.11 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$0.02 | -106.5% | -200.0% |
| October 31, 2025 | $0.02 | -60.0% | +166.7% |
| July 31, 2025 | -$0.03 | -133.3% | -109.7% |
| January 31, 2025 | $0.31 | +263.2% | +520.0% |
| October 31, 2024 | $0.05 | +133.3% | -44.4% |
| July 31, 2024 | $0.09 | +147.4% | +147.4% |
| January 31, 2024 | -$0.19 | -5.6% | -26.7% |
| October 31, 2023 | -$0.15 | — | +21.1% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +161.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2014–2025 period, CHAMPIONS ONCOLOGY, INC.’s diluted eps has grown by 400.0% (from $0.11 per share (loss) to $0.33 per share).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: